Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ
Aime Munro(St John of God Subiaco Hospital), Paul A. Cohen(The University of Western Australia), Katrina Spilsbury(Curtin University), Peter O’Leary(Princess Margaret Hospital for Children), Jim Codde(The University of Notre Dame Australia), James B. Semmens(Queensland Health), Yee Leung(King Edward Memorial Hospital), Vincent Williams(Curtin University), Nerida Steel(Pancreatic Cancer Action Network), Jason Tan(St John of God Subiaco Hospital), Stuart Salfinger(St John of God Subiaco Hospital), Ganendra Raj Mohan(St John of God Subiaco Hospital), Colin J.R. Stewart(King Edward Memorial Hospital)
Cited by 23
Related Papers
<i>BRCA</i> Mutation Frequency and Patterns of Treatment Response in <i>BRCA</i> Mutation–Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
|Journal of Clinical Oncology|2012|1.2k
Driver mutations in <i>TP53</i> are ubiquitous in high grade serous carcinoma of the ovary
|The Journal of Pathology|2010|836
The quanitification of drug caused morbidity and mortality in Australia: Part 1
|UWA Profiles and Research Repository (University of Western Australia)|1995|470
Poor Long-Term Survival in Patients With Moderate Aortic Stenosis
|Journal of the American College of Cardiology|2019|418
Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth.
|Molecular Endocrinology|1993|160